News

US Medicare lays out timeline for third round of drug price negotiations
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
Health Affairs11h
In Price Negotiations, Medicare Should Reassess How It Determines A ‘Qualifying Single Source Drug’
Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...
Fierce Healthcare10h
CMS may add Part B drugs to negotiation program under draft guidance
The Trump administration has issued new draft guidance for the third cycle of Medicare drug price negotiations. | The Trump ...
How soon will drug prices drop? RFK Jr. says timeline depends on big pharma
Health and Human Services Secretary Robert F. Kennedy Jr. said that bringing the cost of prescription drugs to levels seen in ...
National Law Review13h
Appeals Court Rejects AstraZeneca’s Challenge to Medicare Drug Price Negotiation Program
A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...
Trump to unveil Medicare drug pricing plan after teasing "earth-shattering" announcement
President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the ...
Health Affairs4d
Costs Of Extending The Small Molecule Exemption Period In Medicare Drug Price Negotiation
Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...
US court shuts down AstraZeneca's challenge to Medicare drug price plan
A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...
Wall Street Journal knocks Trump on expanding drug price controls: ‘Worst idea since tariffs’
The editorial board of the Wall Street Journal is criticizing President Trump over an executive order expanding drug price ...